It attracts T-regulatory cells allowing for some cancers to evade an immune response. However, in other cancers, such as melanoma, an increase in CCL17 is linked to an improved outcome.
This attracts T-regulatory cells, allowing certain cancers to bypass the immune system's defenses. Conversely, in cases like melanoma, increased levels of CCL17 are correlated with improved outcomes.